Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Jul 24, 2021 5:14pm
172 Views
Post# 33601284

RE:RE:A 3rd CR at 450 days?

RE:RE:A 3rd CR at 450 days?99942Apophis wrote
Of concern to me and am not sure if this has been addressed are the number of No Response in patients. Am I wrong in thinking there were originally 5 patients that had no response in Phase 2 but according to that chart the number at 90 days shows 9 patients  and at 270 & 450 days moves up to 11 patients. Any explanation would be appreciated. 


Thank you all for your thoughts and opinions. Perhaps once Theralase brings back its workforce the 3 month newsletter will have a more professional appearance and clarity,  it does make me think IF they put out the newsletter with the intent of minimal info so to not show competition and big pharma  their progress. 
The newsletter for this quarter is probably days away and we can see if this one gives a clearer picture of Phase 2 after the under dosing discovery. I still have a strong belief that once the return of a full workforce and less of a strain on current personnel to cover jobs they weren't train for that we as shareholders will end up giving them a resounding cheer to those that tried to hold it together at Theralase through this pandemic. 
<< Previous
Bullboard Posts
Next >>